Deal · Completed
Lexeo Therapeutics, Inc. and Mantle continuing as the surviving
First filed 22 Sept 2026, latest filing 29 Sept 2026, 2 filings.
The deal
- Buyer
- Lexeo Therapeutics, Inc.
- Target
- Mantle continuing as the surviving
- Status
- Completed
- Region
- US
On September 16, 2026, Lexeo Therapeutics, Inc. (" Lexeo " or the " Company ") entered into an Agreement and Plan of Merger (the " Merger Agreement ") with Mantle Therapeutics Inc.
Source: The filing (SEC Form 8-K)
With a free account
A free account opens 10 full pages a month and lets you follow this page: alerts on the next filing, buyer lists, exports.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.